Literature DB >> 25948711

Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation.

Kathleen G Barrett1, Hailin Fang1, Daniela Cukovic1, Alan A Dombkowski1, Thomas A Kocarek1, Melissa Runge-Morris2.   

Abstract

During cholestasis, the bile acid-conjugating enzymes, SULT2A1 and UGT2B4, work in concert to prevent the accumulation of toxic bile acids. To understand the impact of sulfotransferase deficiency on human hepatic gene expression, we knocked down 3'-phosphoadenosine-5'-phosphosulfate synthases (PAPSS) 1 and 2, which catalyze synthesis of the obligate sulfotransferase cofactor, in HepG2 cells. PAPSS knockdown caused no change in SULT2A1 expression; however, UGT2B4 expression increased markedly (∼41-fold increase in UGT2B4 mRNA content). Knockdown of SULT2A1 in HepG2 cells also increased UGT2B4 expression. To investigate the underlying mechanism, we transfected PAPSS-deficient HepG2 cells with a luciferase reporter plasmid containing ∼2 Kb of the UGT2B4 5'-flanking region, which included a response element for the bile acid-sensing nuclear receptor, farnesoid X receptor (FXR). FXR activation or overexpression increased UGT2B4 promoter activity; however, knocking down FXR or mutating or deleting the FXR response element did not significantly decrease UGT2B4 promoter activity. Further evaluation of the UGT2B4 5'-flanking region indicated the presence of distal regulatory elements between nucleotides -10090 and -10037 that negatively and positively regulated UGT2B4 transcription. Pulse-chase analysis showed that increased UGT2B4 expression in PAPSS-deficient cells was attributable to both increased mRNA synthesis and stability. Transfection analysis demonstrated that the UGT2B4 3'-untranslated region decreased luciferase reporter expression less in PAPSS-deficient cells than in control cells. These data indicate that knocking down PAPSS increases UGT2B4 transcription and mRNA stability as a compensatory response to the loss of SULT2A1 activity, presumably to maintain bile acid-conjugating activity.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25948711      PMCID: PMC4468435          DOI: 10.1124/dmd.114.061440

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  55 in total

Review 1.  PCR-directed linker scanning mutagenesis.

Authors:  K Gustin; R D Burk
Journal:  Methods Mol Biol       Date:  2000

2.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.

Authors:  J L Staudinger; B Goodwin; S A Jones; D Hawkins-Brown; K I MacKenzie; A LaTour; Y Liu; C D Klaassen; K K Brown; J Reinhard; T M Willson; B H Koller; S A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity.

Authors:  M E Morris; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

4.  Bile acids and their sulphated and glucuronidated derivatives in bile, plasma, and urine of children with intrahepatic cholestasis: effects of phenobarbital treatment.

Authors:  A Stiehl; M Becker; P Czygan; W Fröhling; B Kommerell; H W Rotthauwe; M Senn
Journal:  Eur J Clin Invest       Date:  1980-08       Impact factor: 4.686

5.  Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes.

Authors:  A Radomińska-Pyrek; P Zimniak; Y M Irshaid; R Lester; T R Tephly; J St Pyrek
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

6.  Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.

Authors:  G P van Berge Henegouwen; K H Brandt; H Eyssen; G Parmentier
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

7.  Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

Authors:  C J Sinal; M Tohkin; M Miyata; J M Ward; G Lambert; F J Gonzalez
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

8.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

Authors:  B Goodwin; S A Jones; R R Price; M A Watson; D D McKee; L B Moore; C Galardi; J G Wilson; M C Lewis; M E Roth; P R Maloney; T M Willson; S A Kliewer
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

9.  Glucuronidated and sulfated bile acids in serum of patients with acute hepatitis.

Authors:  H Takikawa; T Beppu; Y Seyama; T Sugimoto
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

10.  MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway.

Authors:  F-y Liu; S-j Zhou; Y-l Deng; Z-y Zhang; E-l Zhang; Z-b Wu; Z-y Huang; X-p Chen
Journal:  Cell Death Dis       Date:  2015-03-05       Impact factor: 8.469

View more
  1 in total

Review 1.  3,5-T2-an Endogenous Thyroid Hormone Metabolite as Promising Lead Substance in Anti-Steatotic Drug Development?

Authors:  Rajas Sane; Eva K Wirth; Josef Köhrle
Journal:  Metabolites       Date:  2022-06-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.